132 related articles for article (PubMed ID: 24521182)
41. Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy.
Laguna MP; Kiemeney LA; Debruyne FM; de la Rosette JJ
J Urol; 2002 Apr; 167(4):1727-30. PubMed ID: 11912397
[TBL] [Abstract][Full Text] [Related]
42. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
43. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
Ghalayini IF; Al-Ghazo MA; Pickard RS
BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
[TBL] [Abstract][Full Text] [Related]
44. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
[TBL] [Abstract][Full Text] [Related]
45. Holmium laser enucleation of the prostate for persistent lower urinary tract symptoms after prior benign prostatic hyperplasia surgery.
Jaeger CD; Krambeck AE
Urology; 2013 May; 81(5):1025-9. PubMed ID: 23465142
[TBL] [Abstract][Full Text] [Related]
46. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
Elshal AM; Elkoushy MA; Elmansy HM; Sampalis J; Elhilali MM
J Urol; 2014 Jan; 191(1):148-54. PubMed ID: 23845460
[TBL] [Abstract][Full Text] [Related]
47. Quantification of prostate shrinkage after microwave thermotherapy: a comparison of calculated cell-kill versus 3D transrectal ultrasound planimetry.
Hoffmann AL; Laguna MP; de la Rosette JJ; Wijkstra H
Eur Urol; 2003 Feb; 43(2):181-7. PubMed ID: 12565777
[TBL] [Abstract][Full Text] [Related]
48. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
49. High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: results of a prospective randomized study with 1 year of followup.
D'Ancona FC; Francisca EA; Witjes WP; Welling L; Debruyne FM; de la Rosette JJ
J Urol; 1997 Jul; 158(1):120-5. PubMed ID: 9186336
[TBL] [Abstract][Full Text] [Related]
50. Intermittent catheterization time required after interstitial laser coagulation of the prostate.
Nishizawa K; Kobayashi T; Mitsumori K; Watanabe J; Ogura K
Urology; 2004 Jul; 64(1):79-83. PubMed ID: 15245940
[TBL] [Abstract][Full Text] [Related]
51. Bipolar plasmakinetic transurethral resection of prostate in 132 consecutive patients with large gland: three-year follow-up results.
Zhu G; Xie C; Wang X; Tang X
Urology; 2012 Feb; 79(2):397-402. PubMed ID: 22035765
[TBL] [Abstract][Full Text] [Related]
52. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
[TBL] [Abstract][Full Text] [Related]
53. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of transurethral ethanol ablation of prostate for symptomatic benign prostatic hyperplasia.
Faruque MS; Alam MK; Ullah MA; Rahman MH; Kibria MG; Haque MM; Haque MA; Joarder AI; Paul BK
Mymensingh Med J; 2012 Apr; 21(2):265-9. PubMed ID: 22561769
[TBL] [Abstract][Full Text] [Related]
55. Intraprostatic botulinum toxin type a injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement. Effect on prostate volume and micturition resumption.
Silva J; Silva C; Saraiva L; Silva A; Pinto R; Dinis P; Cruz F
Eur Urol; 2008 Jan; 53(1):153-9. PubMed ID: 17825981
[TBL] [Abstract][Full Text] [Related]
56. Office-Based HE-TUMT Costs Less than Medication over Four Years in Treating Benign Prostatic Hyperplasia.
Lerner LB; Thurmond P; Harsch MR; Martinson MS
Surg Technol Int; 2015 May; 26():182-9. PubMed ID: 26055008
[TBL] [Abstract][Full Text] [Related]
57. New and experimental techniques in the treatment of benign prostatic diseases.
Pejčić T; Džamić Z; Aćimović M; Kajmaković B; Hadži-Djokić J
Acta Chir Iugosl; 2014; 61(1):75-80. PubMed ID: 25782231
[TBL] [Abstract][Full Text] [Related]
58. A randomised study of TURP after intraprostatic injection of mepicacaine/adrenaline versus regular TURP in patients with LUTS/BPO.
Stenmark F; Brundin L; Gunnarsson O; Kjölhede H; Lekås E; Peeker R; Månsson M; Richthoff J; Stranne J
Scand J Urol; 2023 Aug; 58():46-51. PubMed ID: 37614207
[TBL] [Abstract][Full Text] [Related]
59. Very high residual volumes should not prevent transurethral resection of the prostate being offered to men presenting with urinary retention.
Green W; Campain N; Peracha A; Ratan H; Walton T; Parkinson R
Scand J Urol; 2014 Dec; 48(6):549-53. PubMed ID: 25012873
[TBL] [Abstract][Full Text] [Related]
60. Effect of intraprostatic epinephrine on intraoperative blood loss reduction during transurethral resection of the prostate.
Lira-Dale A; Maldonado-Ávila M; Gil-García JF; Mues-Guizar EH; Nerubay-Toiber R; Guzmán-Esquivel J; Delgado-Enciso I
Int Urol Nephrol; 2012 Apr; 44(2):365-9. PubMed ID: 22002111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
